|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/16 | |||
| A61K 38/31 |
| (11) | Patento numeris | 2376070 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09799316.6 |
| Europos patento paraiškos padavimo data | 2009-12-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-10-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-08-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2009/067049 |
| Data | 2009-12-14 |
| (87) | Numeris | WO 2010/079047 |
| Data | 2010-07-15 |
| (30) | Numeris | Data | Šalis |
| 08171712 | 2008-12-15 | EP |
| (72) |
AHLHEIM, Markus, CH
PETERSEN, Holger, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH RELEASE RATES |
| OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH RELEASE RATES |